Literature DB >> 8822581

Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.

N Okumura1, K Furihata, F Terasawa, R Nakagoshi, I Ueno, T Katsuyama.   

Abstract

Fibrinogen Matsumoto I is a novel hereditary dysfibrinogen identified in a 1-year-old boy with Down's syndrome. Though he showed no apparent bleeding or thrombotic tendency, he had a congenital heart disease. Preoperative coagulation tests of his plasma revealed a prolonged thrombin time and the fibrinogen level determined by the thrombin time method was markedly decreased. Molecular weight of fibrinogen chains showed apparently normal A alpha-, B beta-, and gamma-chains. The rate of fibrinopeptide release was normal, whereas fibrin polymerization was delayed. Fibrinogen gamma-chain gene fragments from the propositus were amplified by polymerase chain reaction then sequenced. The triplet GAT, coding for the amino acid residue gamma 364, was replaced by CAT, resulting in the substitution of Asp-->His. This residue is adjacent to the Tyr-363 that is demonstrated to be the primary site for fibrin polymerization. Our results indicate that the residue gamma 364 Asp is essential for normal polymerization of fibrin monomer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822581

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro.

Authors:  K P Pratt; H C Côté; D W Chung; R E Stenkamp; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 2.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

Authors:  V A Ploplis; J Wilberding; L McLennan; Z Liang; I Cornelissen; M E DeFord; E D Rosen; F J Castellino
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Fibrinogen variant BbetaD432A has normal polymerization but does not bind knob "B".

Authors:  Sheryl R Bowley; Susan T Lord
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

5.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

6.  Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.

Authors:  Tomu Kamijo; Takahiro Kaido; Masahiro Yoda; Shinpei Arai; Kazuyoshi Yamauchi; Nobuo Okumura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

7.  Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.

Authors:  Atsuo Suzuki; Nobuaki Suzuki; Takeshi Kanematsu; Sho Shinohara; Hiroshi Kurono; Nobuo Arai; Shuichi Okamoto; Naruko Suzuki; Shogo Tamura; Ryosuke Kikuchi; Akira Katsumi; Tetsuhito Kojima; Tadashi Matsushita
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.